Biostax Corp.
BTAX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $5,849 | $21,774 | $1,444 | $6,692 |
| - Cash | $30 | $150 | $494 | $10 |
| + Debt | $1,129 | $696 | $3,070 | $2,845 |
| Enterprise Value | $6,948 | $22,320 | $4,020 | $9,527 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,140 | -$3,415 | $3,797 | $2,069 |
| % Margin | – | – | – | – |
| Net Income | -$2,363 | -$3,536 | $3,586 | $1,589 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.03 | -0.1 | 0.38 | 0.11 |
| % Growth | 70% | -126.3% | 245.5% | – |
| Operating Cash Flow | -$408 | -$582 | – | -$192 |
| Capital Expenditures | $0 | -$500 | – | $0 |
| Free Cash Flow | -$408 | -$1,082 | – | -$192 |